A1EB7
Balovaptan
| Created: | 2024-09-20 |
| Last modified: | 2025-11-17 |
Find Related PDB Entry |
|---|
Find related ligands:Help |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 53 |
| Chiral Atom Count | 0 |
| Bond Count | 57 |
| Aromatic Bond Count | 17 |
Chemical Component Summary | |
|---|---|
| Name | Balovaptan |
| Synonyms | 8-chloranyl-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine |
| Systematic Name (OpenEye OEToolkits) | 8-chloranyl-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine |
| Formula | C22 H24 Cl N5 O |
| Molecular Weight | 409.912 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | CACTVS | 3.385 | CN1Cc2nnc([CH]3CC[CH](CC3)Oc4ccccn4)n2c5ccc(Cl)cc5C1 |
| SMILES | OpenEye OEToolkits | 2.0.7 | CN1Cc2cc(ccc2-n3c(nnc3C4CCC(CC4)Oc5ccccn5)C1)Cl |
| Canonical SMILES | CACTVS | 3.385 | CN1Cc2nnc([C@@H]3CC[C@H](CC3)Oc4ccccn4)n2c5ccc(Cl)cc5C1 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | CN1Cc2cc(ccc2-n3c(nnc3C4CCC(CC4)Oc5ccccn5)C1)Cl |
| InChI | InChI | 1.06 | InChI=1S/C22H24ClN5O/c1-27-13-16-12-17(23)7-10-19(16)28-20(14-27)25-26-22(28)15-5-8-18(9-6-15)29-21-4-2-3-11-24-21/h2-4,7,10-12,15,18H,5-6,8-9,13-14H2,1H3/t15-,18- |
| InChIKey | InChI | 1.06 | GMPZPHGHNDMRKL-RZDIXWSQSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB14823 |
|---|---|
| Name | Balovaptan |
| Description | Balovaptan is under investigation in clinical trial NCT01793441 (A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)). |
| Synonyms | Balovaptan |
| Categories |
|
| CAS number | 1228088-30-9 |














